[go: up one dir, main page]

HK1231753A1 - Methods for activating t cells using an inducible chimeric polypeptide - Google Patents

Methods for activating t cells using an inducible chimeric polypeptide Download PDF

Info

Publication number
HK1231753A1
HK1231753A1 HK17105444.2A HK17105444A HK1231753A1 HK 1231753 A1 HK1231753 A1 HK 1231753A1 HK 17105444 A HK17105444 A HK 17105444A HK 1231753 A1 HK1231753 A1 HK 1231753A1
Authority
HK
Hong Kong
Prior art keywords
cells
methods
activating
chimeric polypeptide
inducible chimeric
Prior art date
Application number
HK17105444.2A
Other languages
Chinese (zh)
Inventor
Aaron Edward FOSTER
David Spencer
Matthew Robert COLLINSON-PAUTZ
Kevin Slawin
Original Assignee
Bellicum Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellicum Pharmaceuticals, Inc. filed Critical Bellicum Pharmaceuticals, Inc.
Publication of HK1231753A1 publication Critical patent/HK1231753A1/en

Links

Abstract

The technology relates generally to the field of immunology and relates in part to methods for activating cells, including for example T cells and T cells that express chimeric antigen receptors, using an inducible chimeric polypeptide including CD40, MyD88, or CD40 and MyD88 polypeptides. The technology further relates in part to therapeutic methods for inducing an immune response and treating tumors in a patient.
HK17105444.2A 2014-02-14 2015-02-13 Methods for activating t cells using an inducible chimeric polypeptide HK1231753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/940,347 2014-02-14
US61/952,839 2014-03-13
US62/047,875 2014-09-09

Publications (1)

Publication Number Publication Date
HK1231753A1 true HK1231753A1 (en) 2017-12-29

Family

ID=

Similar Documents

Publication Publication Date Title
IL278920A (en) Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies
IL267129A (en) Novel t cell receptors and immune therapy using the same
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12018502400A1 (en) Anti-tim-3 antibodies and methods of use thereof
PH12016501644A1 (en) Binding proteins and methods of use thereof
MX2021001098A (en) Single domain antibodies directed against intracellular antigens.
MX382129B (en) MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITOPE AND THEIR METHODS OF USE.
WO2016100241A3 (en) Methods for controlled activation or elimination of therapeutic cells
SG11201911437VA (en) Novel t cell receptors and immune therapy using the same
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
WO2016100985A3 (en) Chimeric antigen receptors and methods of use thereof
NZ731467A (en) Anti-tim3 antibodies and methods of use
PH12017500825A1 (en) Anti-cldn chimeric antigen receptors and methods of use
MX2017005774A (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use.
EP3105333A4 (en) Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer
ZA201900664B (en) T cell receptors and immune therapy using the same
MX2017003691A (en) Methods of treating systemic lupus erythematosus using a domain antibody directed against cd28.
WO2015187992A3 (en) Map44 polypeptides and constructs based on natural antibodies and uses thereof
MX2019006446A (en) Methods of inducing immune tolerance to clotting factors.
HK1231753A1 (en) Methods for activating t cells using an inducible chimeric polypeptide
HK1240265A1 (en) Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
WO2015175599A3 (en) Immunotherapy with binding agents
IL267131A (en) Novel t cell receptors and immune therapy using the same
IL264855B1 (en) T cell receptors and immune therapy using the same
HK40028714A (en) Novel t cell receptors and immune therapy using the same